ClearPoint Neuro, Inc.
CLPT
$9.42
-$0.09-0.95%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -35.03% | -27.51% | -23.58% | -0.81% | 14.37% |
| Total Depreciation and Amortization | 12.35% | 0.05% | 7.96% | 6.20% | 30.61% |
| Total Amortization of Deferred Charges | 256.86% | -9.09% | -25.86% | -37.93% | -10.53% |
| Total Other Non-Cash Items | 37.79% | 33.74% | 24.69% | 3.04% | -8.32% |
| Change in Net Operating Assets | -801.50% | -190.85% | 1,335.09% | 353.79% | 492.98% |
| Cash from Operations | -167.32% | -47.45% | -17.87% | 5.03% | 34.77% |
| Capital Expenditure | -89.82% | -2,130.30% | -114.45% | 20.90% | 61.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 323.64% | -268.00% | -29.79% | -105.04% | -103.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -76.23% | -77.56% | -77.56% | -97.43% | 3,183.20% |
| Repurchase of Common Stock | -337.74% | -362.86% | -343.73% | -343.26% | -101.90% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 710.78% | 386.00% | 26.50% | -168.64% | 1,990.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 985.01% | 707.73% | 39.10% | -269.35% | 32.16% |